X4 Pharmaceuticals Inc. (XFOR)
NASDAQ: XFOR
· Real-Time Price · USD
2.84
-0.30 (-9.55%)
At close: Aug 15, 2025, 3:59 PM
2.80
-1.41%
After-hours: Aug 15, 2025, 07:54 PM EDT
X4 Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 39.22M | 40.26M | 55.7M | 97.41M | 147.22M | 60.49M | 99.47M | 131.58M | 136.43M | 136.43M | 93.41M | 121.72M | 47.38M | 66.43M | 81.79M | 76.39M | 95.16M | 114.94M |
Short-Term Investments | 23.73M | 46.69M | 46.36M | 37.56M | 21.54M | 20.38M | 15M | 10.1M | 4.88M | 4.88M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 802K | n/a | n/a | 788K | 778K | 777K | 782K | n/a | 778K | 777K | 1.02M | 1.29M | 1.3M | 1.32M | 1.32M | 1.33M | 227K | 1.72M |
Other Long-Term Assets | 1.55M | 3.01M | 2.08M | 1.57M | 1.79M | 715K | 654K | 2.02M | 1.08M | 1.08M | 1M | 1.23M | 1.8M | 1.65M | 1.72M | 2M | 2M | 2.39M |
Receivables | 1.15M | 1.17M | 1.71M | 1.07M | 854K | 702K | 562K | 393K | 820K | 658K | 1.15M | 909K | 843K | 868K | 747K | 646K | 1.05M | 768K |
Inventory | 3.17M | 3.09M | 2.82M | 2.44M | 831K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -843K | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 5.68M | 4.48M | 5.59M | n/a | 4.98M | 5.76M | 7.05M | 5.8M | 5.52M | 4.16M | 5.81M | 909K | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 72.94M | 95.7M | 112.17M | 142.97M | 175.42M | 87.33M | 122.08M | 147.87M | 147.65M | 147.65M | 98.22M | 128.68M | 52.59M | 70.88M | 87.88M | 80.7M | 101.37M | 119.96M |
Property-Plant & Equipment | 2.9M | 4.14M | 4.84M | 5.29M | 5.68M | 6.01M | 6.39M | 6.83M | 7.32M | 7.32M | 7.83M | 8.33M | 9.29M | 9.75M | 10.22M | 10.7M | 11.18M | 11.58M |
Goodwill & Intangibles | 26.98M | 27.16M | 27.35M | 27.54M | 27.73M | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M | 27.11M | 27.11M | 27.11M |
Total Long-Term Assets | 32.23M | 34.32M | 34.27M | 35.19M | 35.2M | 24.85M | 25.18M | 25.42M | 25.75M | 25.75M | 26.18M | 26.91M | 28.43M | 28.74M | 29.3M | 39.82M | 40.29M | 41.08M |
Total Assets | 105.17M | 130.01M | 146.45M | 178.16M | 210.61M | 112.18M | 147.26M | 173.29M | 173.4M | 173.4M | 124.41M | 155.59M | 81.02M | 99.63M | 117.18M | 120.52M | 141.66M | 161.03M |
Account Payables | 7.71M | 11.12M | 8.62M | 8.58M | 7.99M | 8.94M | 8.95M | 8.13M | 5.11M | 5.99M | 7.78M | 3.8M | 3.68M | 3.57M | 4.28M | 2.42M | 2.53M | 3.09M |
Deferred Revenue | 754K | 855K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.37M | n/a | n/a | 1.22M | n/a | 1.13M | 1.1M | 1.12M | 1.91M | 554K | 1.31M | 14.62M | 9.74M | 4.52M | 1.87M | 1.73M | 985K | 875K |
Other Current Liabilities | 6.7M | 12.61M | 13.05M | 9.03M | 12.57M | -1.13M | 7.1M | 9M | 8.41M | n/a | 591K | n/a | 3.17M | 2.67M | 4.34M | 3.72M | 5.6M | 7.25M |
Total Current Liabilities | 22.9M | 25.88M | 32.88M | 29.26M | 28.9M | 23.54M | 22.86M | 25.43M | 22.25M | 22.25M | 19.48M | 22.32M | 22M | 14.97M | 14.02M | 13.23M | 13.12M | 14.67M |
Long-Term Debt | 815K | 75.63M | 75.42M | 75.22M | 75.03M | 54.82M | 54.57M | 54.32M | 31.84M | 31.83M | 32.3M | 18.73M | 24.49M | 29.81M | 33.14M | 33.04M | 33.54M | 33.36M |
Other Long-Term Liabilities | 77.49M | 3.49M | 14.59M | 12.3M | 10.2M | 30.46M | 16.11M | 23.1M | 48.65M | 18.04M | 23.3M | 312K | 314K | 650K | 826K | 496K | 434K | 491K |
Total Long-Term Liabilities | 78.3M | 81.19M | 91.42M | 89.29M | 87.26M | 87.61M | 73.3M | 80.27M | 83.61M | 83.61M | 53.25M | 59.21M | 28.94M | 34.94M | 38.74M | 38.61M | 126.66M | 39.43M |
Total Liabilities | 101.2M | 107.07M | 124.3M | 118.54M | 116.16M | 111.15M | 96.16M | 105.7M | 105.86M | 105.86M | 72.73M | 81.53M | 50.95M | 49.91M | 52.76M | 51.84M | 139.78M | 54.1M |
Total Debt | 2.18M | 78.04M | 78.09M | 78.2M | 78.23M | 58.27M | 58.28M | 58.29M | 36.87M | 36.87M | 36.93M | 38.42M | 38.37M | 38.81M | 39.78M | 39.84M | 39.88M | 39.81M |
Common Stock | 8K | 6K | 171K | 168K | 168K | 168K | 167K | 165K | 164K | 164K | 122K | 122K | 31K | 31K | 28K | 25K | 1.88M | 1.9M |
Retained Earnings | -540.81M | -515.07M | -515.36M | -475.53M | -438.84M | -529.67M | -477.9M | -458.77M | -456.47M | -456.47M | -400.76M | -376.74M | -326.05M | -304.84M | -282.87M | -252.66M | -232.49M | -212.85M |
Comprehensive Income | -138K | -128K | -122K | -114K | -159K | -155K | -119K | -119K | -119K | -119K | -119K | -119K | -119K | -119K | -119K | -119K | -119K | -119K |
Shareholders Equity | 3.97M | 22.94M | 22.15M | 59.62M | 94.45M | 1.04M | 51.1M | 67.59M | 67.53M | 67.53M | 51.68M | 74.05M | 30.07M | 49.71M | 64.41M | 68.68M | 1.88M | 106.94M |
Total Investments | 24.53M | 46.69M | 46.36M | 37.56M | 22.31M | 21.15M | 15.78M | 10.1M | 4.88M | 4.88M | 1.02M | 1.29M | 1.3M | 1.32M | 1.32M | 1.33M | 227K | 1.72M |